Table 3.
Vaccine | Reported Critical Adverse Reaction | Reference |
---|---|---|
Pfizer/BioNTech | (1) Myocarditis, pericarditis, or myopericarditis (about 1–10 cases per 100,000 persons). (2) Vein thrombosis and pulmonary thromboembolism (only one case report). |
[57,58,59,60] |
Moderna | ||
Oxford/AstraZeneca (AZ) | Vaccine-induced immune thrombocytopenia and thrombosis (VITT) (incidence apparently between 1 in 125,000 and 1 in 1,000,000). | [61] |
Johnson & Johnson | ||
Sputnik V | Panniculitis (only one case report). | [62] |
BBIBP-CorV | (1) VITT (incidence apparently between 1 in 125,000 and 1 in 1,000,000). (2) Transverse myelitis. |
[63,64] |
CoronaVac | ||
Novavax | Myocarditis (only one case report). | [65] |
Medigen | Multiple evanescent white-dot syndrome (MEWDS) in the eyes (only one case report). | [66] |